Date lodged: 14 November 2016
To ask the Scottish Government, in light of the Scottish Medicines Consortium's decision not to recommend nivolumab for use by patients with advanced renal cell carcinoma, what options it is considering to make this treatment available.
Answered by: Shona Robison 24 November 2016
I refer the member to the answer to question S5W-04618 on 21 November 2016. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at http://www.parliament.scot/parliamentarybusiness/28877.aspx